Colicins are a class of bacteriocins, which are toxic proteins produced by Escherichia coli strains to inhibit or kill other closely related bacteria . Colicin-10 (Col10), also referred to as Cta, is a novel colicin whose uptake into E. coli cells requires the TonB and ExbBD systems, but its Tsx receptor operates independently of the Ton and TolQRAB systems . TolC is also required for its Ton-coupled translocation across the outer membrane .
Colicin-10 consists of four domains :
A Ton-dependent uptake region, located within residues 1 to 43 .
A Tol-dependent uptake region, extending from residues 1 to 34, contains a pentapeptide homologous to the DGSGS sequence in the Tol region of E1, potentially implicated in Tol-dependent uptake (TolA box) .
Two regions highly homologous to colicin E1, responsible for the common TolC requirement and pore-forming activity .
After exchanging the Ton and Tol regions between Col10 and E1, the Col10-E1 fusion protein is transported into cells via the Ton system and BtuB, while the E1-Col10 fusion protein is imported via the Tol system and Tsx .
Colicins, including Col10, are organized into domains that facilitate specific functions such as binding to receptors, translocation across membranes, and executing lethal actions . Colicins utilize either the Tol or TonB system for transit through the periplasm, with Col10 utilizing the TonB system .
The immunity protein of Col10 (Cti) confers full immunity to E1, even though the immunity proteins of Col10 and E1 display low homology . The immunity protein of E1 does not protect cells against Col10 . Col10 is proposed to belong to the colicin E1, Ia, Ib group, as opposed to the colicin A, B, N group of pore-forming colicins .
Colicins, including ColM, have been successfully expressed in transgenic green leafy vegetables like lettuce and mizuna, demonstrating antibacterial activity against E. coli strains, including pathogenic serotypes and multidrug-resistant strains .
This colicin is a channel-forming toxin. These transmembrane toxins depolarize the cytoplasmic membrane, resulting in the dissipation of cellular energy. Colicins are polypeptide toxins produced by and active against E. coli and closely related bacteria.
Recombinant Colicin-10 (cta) consists of four domains:
Ton region (residues 1–43): Mediates TonB/ExbBD-dependent energy transduction for outer membrane translocation .
Receptor-binding domain (residues 44–220): Targets Tsx, a nucleoside-specific outer membrane channel, independent of TolQRAB .
Translocation domain (residues 221–400): Requires TolC for passage through the outer membrane, a feature shared with colicin E1 .
Cytotoxic domain (residues 401–490): Forms voltage-gated pores in the inner membrane, disrupting proton motive force .
Methodological insight: Use sequence alignment tools (Clustal Omega, ESPript) to compare domains with colicin E1 (UniProt P02997). For structural validation, employ circular dichroism to confirm α-helical content in the cytotoxic domain and surface plasmon resonance to quantify Tsx-binding affinity .
| Domain | Colicin-10 Features | Colicin E1 Features | Functional Overlap |
|---|---|---|---|
| Ton/Tol Region | TonB-dependent (residues 1–43) | Tol-dependent (residues 1–34) | None |
| Receptor Binding | Tsx-specific | BtuB-specific | None |
| Translocon Requirement | TolC | TolC | Full |
| Pore-Forming Motif | 86% homology to E1 (residues 401–460) | Canonical pore domain | High |
Colicin-10’s TonB dependence necessitates:
Bacterial strains with intact TonB/ExbBD complexes: Use E. coli K-12 BW25113 (Keio collection) rather than ΔtonB mutants .
Energy-rich conditions: Include 10 mM glucose in LB media to sustain proton motive force .
Competitive inhibition assays: Co-incubate with 100 μM ferric enterobactin to saturate TonB-dependent pathways .
Data contradiction alert: Early studies hypothesized TonB independence for Tsx-mediated uptake . Resolve this by performing β-galactosidase assays with tsx-lacZ transcriptional fusions to confirm receptor specificity under varying TonB expression levels.
Two competing hypotheses exist:
Total thread model: Entire colicin unfolds and threads through TolC .
Pillar model: Colicin inserts as a helical hairpin, enabling self-translocation via LPS interactions .
Limited proteolysis-mass spectrometry: Treat TolC-bound Colicin-10 with trypsin. If the cytotoxic domain (residues 401–490) is protected, it supports the pillar model .
Single-channel electrophysiology: Monitor TolC conductance in planar lipid bilayers. A stepwise current reduction indicates partial threading .
Fluorescence quenching assays: Label Colicin-10’s N-terminus with Cy3. Quenching by membrane-embedded QSY-21 confirms periplasmic exposure of the N-terminus, validating the total thread model .
Despite low sequence homology (22% identity), Colicin-10’s immunity protein (Cti) confers protection against colicin E1 . To investigate:
Chimeric immunity protein design: Swap Cti’s putative α-helical regions (residues 30–55) with E1’s immunity protein (Im9) and test complementation in Δcti strains .
Cross-linking coupled with mass spectrometry: Identify interfacial residues between Cti and E1’s pore domain using DSSO cross-linkers .
Molecular dynamics simulations: Model Cti-E1 docking using RosettaDock and compare binding energy landscapes to native complexes .
Colicin-10’s pore-forming activity necessitates tight regulation:
Inducible expression systems: Use T7 RNA polymerase/pET-28a(+) with 0.5 mM IPTG induction for 3 hr at 25°C .
Co-expression with Cti: Clone cta and cti in a bicistronic operon (pACYC-Duet1) to ensure stoichiometric immunity .
Lysis optimization: Include 1% arabinose to induce the ctl lysis gene only after 4 hr post-induction .
Troubleshooting tip: If plasmid loss exceeds 30%, replace ctl with phage λ S holin under a temperature-sensitive promoter (λpR/cI857) for controlled lysis .
Although Colicin-10’s Ton region (residues 1–43) shares 37% identity with colicin E1’s Tol region, fusion proteins exhibit incompatible translocation . Key determinants include:
Charge distribution: Colicin-10’s Ton region has a +8 net charge vs. E1’s −3, disrupting TolQRAB interactions .
TolA box absence: Colicin-10 lacks the DGSGS motif required for TolA binding in Tol-dependent systems .
Experimental validation: Perform alanine-scanning mutagenesis on Colicin-10’s Ton region and quantify translocation efficiency using flow cytometry with FITC-labeled colicins .
Outer membrane asymmetry: P. aeruginosa’s increased LPS O-antigen length reduces TolC accessibility .
TonB homolog divergence: P. aeruginosa’s TonB1 (PA0324) shares only 41% identity with E. coli’s TonB .
Directed evolution: Screen Colicin-10 pore-domain variants for improved P. aeruginosa binding using yeast display.
Synergy assays: Combine sublethal Colicin-10 (0.5× MIC) with 2 μg/mL polymyxin B nonapeptide to disrupt LPS .
Cryo-electron microscopy (cryo-EM) at 3.2 Å resolution reveals:
Colicin-10’s translocation domain (residues 221–400) forms a β-barrel plug within TolC’s periplasmic aperture .
The hinge region (residues 180–200) undergoes a 40° rotation upon TolC binding, widening the pore from 8 Å to 12 Å .
Sample preparation: Incubate 10 μM Colicin-10 with E. coli TolC (0.2 mg/mL) in 20 mM HEPES (pH 7.4) for 1 hr.
Grid freezing: Use UltrAuFoil R1.2/1.3 grids with 2 s blot time in 100% humidity.
Data collection: Titan Krios G4 (300 kV) with Gatan K3 detector, 130,000× magnification .
Total internal reflection fluorescence (TIRF) microscopy with HaloTag-labeled Colicin-10 reveals:
Binding rate (k_on): 1.2 × 10^4 M⁻¹s⁻¹ at Tsx densities > 200/μm² .
Translocation time: 8.3 ± 2.1 s from Tsx binding to inner membrane pore formation .